STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
AMLX
(AMLX)
AMLX
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$1.14B
+343.5%
P/E Ratio
-7.89
-824.6%
P/S Ratio
0.00
ROE
-47.41%
+74.1%
ROIC
-49.26%
+73.9%
FCF Yield
-10.81%
+83.4%
Debt/Equity
0.02
+62.3%
Current Ratio
14.27
+113.9%
Interest Coverage
0.00x
Per Share
Revenue/Share
$0.00
Net Income/Share
$-1.53
+65.4%
Operating CF/Share
$-1.30
+47.0%
Free CF/Share
$-1.31
+47.0%
Cash/Share
$3.35
+29.4%
Book Value/Share
$3.23
+33.5%
Tangible Book/Share
$3.23
+33.5%
Equity/Share
$3.23
+33.5%
Interest Debt/Share
$0.06
+116.7%
Valuation
Market Cap
$1.14B
+343.5%
Enterprise Value
$921.66M
+405.9%
P/E Ratio
-7.89
-824.6%
P/S Ratio
0.00
P/OCF Ratio
-9.26
-502.8%
P/FCF Ratio
-9.25
-502.7%
P/B Ratio
3.74
+139.4%
P/TB Ratio
3.74
+139.4%
EV/Sales
0.00
EV/EBITDA
-6.39
-921.2%
Profitability
Earnings Yield
-12.67%
+89.2%
FCF Yield
-10.81%
+83.4%
ROE
-47.41%
+74.1%
ROIC
-49.26%
+73.9%
Return on Tangible Assets
-43.51%
+72.1%
Capital Allocation
CapEx/OCF
-0.11%
-19.5%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.26
+51.4%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.02
+62.3%
Debt/Assets
0.02
+75.0%
Net Debt/EBITDA
1.53
+490.7%
Current Ratio
14.27
+113.9%
Interest Coverage
0.00x
Income Quality
0.85
+53.4%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
2447 days
+9514.3%
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.15x
-99.0%
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$3.06
+41.1%
Amylyx Pharmaceuticals, Inc.
(AMLX)
$13.29
▼
-0.59 (-4.29%)
Chart
Share
Post on X
AMLX
Amylyx Pharmaceuticals, Inc.
(AMLX)
NASDAQ
$13.29
▼
-0.59 (-4.29%)
Chart Studio
Share
AMLX